{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:28:14Z","timestamp":1791041294126,"version":"4.1.0"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Prior to current studies on the emergence of drug resistance with the introduction of antiretroviral therapy (ART) in Cameroon, we performed genotypic analysis on samples from drug-nai\u0308ve, human immunodeficiency virus (HIV)-infected individuals in this country. Of the 79 HIV type 1 (HIV-1)<jats:italic>pol<\/jats:italic>sequences analyzed from Cameroonian samples, 3 (3.8%) were identified as HIV-1 group O, 1 (1.2%) was identified as an HIV-2 intergroup B\/A recombinant, and the remaining 75 (95.0%) were identified as HIV-1 group M. Group M isolates were further classified as subtypes A1 (<jats:italic>n<\/jats:italic>= 4), D (<jats:italic>n<\/jats:italic>= 4), F2 (<jats:italic>n<\/jats:italic>= 6), G (<jats:italic>n<\/jats:italic>= 12), H (<jats:italic>n<\/jats:italic>= 2), and K (<jats:italic>n<\/jats:italic>= 1) and as circulating recombinant forms CRF02_AG (<jats:italic>n<\/jats:italic>= 41), CRF11_cpx (<jats:italic>n<\/jats:italic>= 1), and CRF13_cpx (<jats:italic>n<\/jats:italic>= 2). Two<jats:italic>pol<\/jats:italic>sequences were identified as unique recombinant forms of CRF02_AG\/F2 (<jats:italic>n<\/jats:italic>= 2). M46L (<jats:italic>n<\/jats:italic>= 2), a major resistance mutation associated with resistance to protease inhibitors, was observed in 2\/75 (2.6%) group M samples. Single mutations associated with resistance to nucleoside reverse transcriptase inhibitors (T215Y\/F [<jats:italic>n<\/jats:italic>= 3]) and nonnucleoside reverse transcriptase inhibitors (V108I [<jats:italic>n<\/jats:italic>= 1], L100I [<jats:italic>n<\/jats:italic>= 1], and Y181C [<jats:italic>n<\/jats:italic>= 2]) were observed in 7 of 75 (9.3%) group M samples. None of the patients had any history of ART exposure. Population surveillance of transmitted HIV drug resistance is required and should be included to aid in the development of appropriate guidelines.<\/jats:p>","DOI":"10.1128\/jcm.00428-07","type":"journal-article","created":{"date-parts":[[2007,9,14]],"date-time":"2007-09-14T00:54:07Z","timestamp":1189731247000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":40,"title":["Molecular Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 in Yaounde\u0301, Cameroon: Evidence of Major Drug Resistance Mutations in Newly Diagnosed Patients Infected with Subtypes Other than Subtype B"],"prefix":"10.1128","volume":"46","author":[{"given":"Nicaise","family":"Ndembi","sequence":"first","affiliation":[{"name":"Laboratory of Hematology and Virology, Faculty of Medicine and Biomedical Sciences, University of Yaounde\u0301 I, Yaounde\u0301, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awet","family":"Abraha","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, 2109 Adelbert Rd., Cleveland, Ohio 44195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Pilch","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, 2109 Adelbert Rd., Cleveland, Ohio 44195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ichimura","sequence":"additional","affiliation":[{"name":"Department of Viral Infection and International Health, School of Medicine, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Mbanya","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology and Virology, Faculty of Medicine and Biomedical Sciences, University of Yaounde\u0301 I, Yaounde\u0301, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazare","family":"Kaptue","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology and Virology, Faculty of Medicine and Biomedical Sciences, University of Yaounde\u0301 I, Yaounde\u0301, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Salata","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, 2109 Adelbert Rd., Cleveland, Ohio 44195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Arts","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, 2109 Adelbert Rd., Cleveland, Ohio 44195"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2005.21.430"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.5.3534-3538.1998"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200301030-00001","volume":"17","year":"2003","unstructured":"Brenner, B., D. Turner, M. Oliveira, D. Moisi, M. Detorio, M. Carobene, R. G. Marlink, J. Schapiro, M. Roger, and M. A. Wainberg. 2003. A V106 mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non nucleoside reverse transcriptase inhibitors. AIDS17:F1-F5.","journal-title":"AIDS"},{"key":"e_1_3_2_5_2","unstructured":"Abstr. 14th Int. AIDS Conf. 2002"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.11.8893-8898.1997"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.3.837-845.2002"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.11.7433-7447.1994"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.10.5390-5401.2004"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.24.2000"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200205240-00010"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2524.2006.00602.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020325"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01731581"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000226793.16216.55"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/0889222041217464"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922204322749558"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16586-0"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1206.050860"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/08892220152644269"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2006.02.008"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200412150-00019"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2006.22.812"},{"key":"e_1_3_2_24_2","first-page":"4","volume":"6","year":"2004","unstructured":"Nkengasong, J. N., C. Adje-Toure, and P. J. Weidle. 2004. HIV antiretroviral drug resistance in Africa. AIDS Rev.6:4-12.","journal-title":"AIDS Rev."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200312050-00002"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922204323048104"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2005.21.602"},{"key":"e_1_3_2_28_2","first-page":"406","volume":"4","year":"1987","unstructured":"Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol.4:406-425.","journal-title":"Mol. Biol. Evol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6822(03)00167-3"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200202010-00009"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200317003-00005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.11.3919-3925.2000"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/135965350601100511","volume":"11","year":"2006","unstructured":"Vergne, L., S. Diagbouga, C. Kouanfack, A. Aghokeng, C. Butel, C. Laurent, N. Noumssi, M. Tardy, A. Sawadogo, J. Drabo, H. Hien, L. Zekeng, E. Delaporte, and M. Peeters. 2006. HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon. Antivir. Ther.11:575-579.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/432916"},{"key":"e_1_3_2_35_2","unstructured":"3 by 5 progress report. 2005"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922203322588332"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2006.22.83"},{"key":"e_1_3_2_38_2","first-page":"319","volume":"5","year":"1992","unstructured":"Zekeng, L., R. Salla, L. Kaptue, P. Pinay, P. Barth, B. Schmidt-Ehry, and T. Rehle. 1992. HIV-2 infection in Cameroon: no evidence of indigenous cases. J. Acquir. Immune Defic. Syndr.5:319-320.","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00428-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00428-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T04:12:06Z","timestamp":1684037526000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00428-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1128\/JCM.00428-07"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00428-07","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"2007-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-09-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}